SCHEMBL11926281

SCHEMBL11926281

Cc1[nH]c2ccc(NC(=O)c3cc(NCC(=O)N4CCC(C(N)=O)CC4)nc(N4CCOCC4)n3)cc2c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 5/20 0.42
▸ MTOR P42345 5/20 0.42
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HSD17B10 Q99714 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MCHR1 Q99705 1/20 0.36
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ GBA1 P04062 1/20 0.36
▸ RAF1 P04049 4/20 0.36
▸ BRAF P15056 4/20 0.36
▸ TLR9 Q9NR96 1/20 0.35
▸ TLR8 Q9NR97 1/20 0.35
▸ TLR7 Q9NYK1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11926284 0.92 KDM4E (0.40) KDM4EALDH1A1L3MBTL1HSD17B10MEN1
SCHEMBL11926274 0.92 ALDH1A1 (0.43) KDM4EALDH1A1L3MBTL1HSD17B10MEN1
SCHEMBL11926290 0.90 ALDH1A1 (0.43) KDM4EALDH1A1L3MBTL1HSD17B10MEN1
SCHEMBL11926291 0.90 ALDH1A1 (0.44) PIK3CAMTORKDM4EALDH1A1L3MBTL1
SCHEMBL11926286 0.89 KDM4E (0.41) PIK3CAMTORPIK3CDPIK3CBKDM4E
SCHEMBL11926282 0.89 ALDH1A1 (0.41) KDM4EALDH1A1L3MBTL1HSD17B10MEN1
SCHEMBL11926287 0.88 ALDH1A1 (0.42) PIK3CAKDM4EALDH1A1L3MBTL1HSD17B10
SCHEMBL3116305 0.86 PIN1 (0.44) PIK3CAKDM4EALDH1A1L3MBTL1HSD17B10
SCHEMBL11926288 0.84 KDM4E (0.42) PIK3CAMTORKDM4EALDH1A1L3MBTL1
SCHEMBL3103694 0.84 PIK3CA (0.42) PIK3CAKDM4EALDH1A1L3MBTL1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8236795-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2012-08-07 — — US disclosed
US-8236795-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2012-08-07 — — US disclosed
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORPORATION (US) 2010-10-07 — — US disclosed
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS SYNTA PHARMACEUTICALS CORPORATION (US) 2010-10-07 — — US disclosed
US-7696202-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2010-04-13 — — US disclosed
US-7696202-B2 IL-12 modulatory compounds SYNTA PHARMACEUTICALS CORP. (US) 2010-04-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256132-A1 IL-12 MODULATORY COMPOUNDS IL2, IL4, IFNG PIK3CA 2810/4885MTOR 578/4885PIK3CD 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback